ArticleScientific reports2026
Experimental and computational analyses for elucidation of structural, electronic, thermal, and vibrational properties of ethionamide crystal.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ethionamide (ETH) is a second-line drug widely used to treat multidrug-resistant tuberculosis (MDR-TB), but its low aqueous solubility compromises bioavailability and limits its therapeutic efficacy. To understand the ways to improve these properties, we combined experimental and computational approaches to elucidate the structural, electronic, thermal, and vibrational properties of ETH crystals. Powder X-ray diffraction analysis revealed a monoclinic crystal system (C1c1-space group), stabilized by intermolecular interactions, primarily H⋯H (49.3%) and H⋯S/S⋯H (22.1%) contacts. Energy framework analysis revealed the anisotropic nature of intermolecular interactions, with dispersion forces accounting for approximately 60% of the total stabilization energy, while Coulombic interactions showed significant directionality along the crystallographic a-axis and within the bc-plane. The total energy framework indicated that the strongest stabilization propagates along the b-axis, suggesting the formation of highly stable molecular chains, which directly influence crystal morphology and dissolution behavior. Thermal analysis confirmed ETH stability up to 162.2 °C, with melting and decomposition events characterized by endothermic peaks. Density functional theory (DFT) calculations confirmed ETH high electronic gap (7.84–8.09 eV), indicating low reactivity, while solvation studies highlighted its greater stability in polar solvents like water and methanol. Theoretical nuclear magnetic resonance studies (1H and13C) showed minimal solvent influence on chemical shifts, reinforcing the structural stability of ETH across environments. Vibrational spectroscopy, supported by DFT, identified key modes associated with the pyridine ring, NH2, and C=S groups. Hirshfeld surface analysis further revealed the dominance of hydrogen bonds and van der Waals interactions, with minimal void space (5.3%) in the crystal lattice. Electrostatic potential maps identified electron-rich regions around nitrogen atoms as potential sites for hydrogen bonding and protonation, which are relevant for pharmacological interactions. These findings offer critical insights for optimizing ETH’s solid-state properties to enhance its solubility and bioavailability, paving the way for improved formulations against MDR-TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.